Captrust Financial Advisors Cardiovascular Systems Inc Transaction History

Captrust Financial Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$13.53 - $23.34 $6,426 - $11,086	-475 Reduced 10.18%	4,190 $60,000
Q1 2022 May 16, 2022	BUY	$16.14 - $22.6 $34,878 - $48,838	2,161 Added 86.3%	4,665 $105,000
Q4 2021 Feb 14, 2022	SELL	$18.64 - $36.77 $146,473 - $288,938	-7,858 Reduced 75.83%	2,504 $47,000
Q3 2021 Nov 16, 2021	BUY	$32.83 - $43.0 $85,554 - $112,058	2,606 Added 33.6%	10,362 $340,000
Q2 2021 Aug 16, 2021	BUY	$34.41 - $44.03 $1,582 - $2,025	46 Added 0.6%	7,756 $331,000
Q1 2021 May 17, 2021	BUY	$37.29 - $47.19 $1,715 - $2,170	46 Added 0.6%	7,710 $296,000
Q4 2020 Feb 16, 2021	SELL	$34.3 - $44.09 $203,536 - $261,630	-5,934 Reduced 43.64%	7,664 $335,000
Q3 2020 Nov 17, 2020	BUY	$27.86 - $39.35 $378,840 - $535,081	13,598 New	13,598 $513,000

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.